RT @ingentium_mel: Benefits and harms of implementing [F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study. h…
Benefits and harms of implementing [F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study. https://t.co/7eajvhS5O7 https://t.co/bzCKIwnR6q
Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study https://t.co/jxnI0eN7io
New article: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study https://t.co/XAleERArUi #melanoma #oncology https://t.co/tfBiwJv8Yr
New article: Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study https://t.co/2vY8nPylv1 #kidneycancer #oncology https://t.co/XiQZX9VAtn
Vi har set på fordele og ulemper ved udredning med #FDGPETCT hos kvinder, der mistænkes for tilbagefald af #brystkræft. PET/CT er god til at be-eller afkræfte tilbagefald, men 1/6 blev udredt for falsk-positive tilfældige fund ⬇️ #bcsm https://t.co/4uG1Vja